Symbiotec Pharmalab posts nearly 53% YoY fall in Q1 PAT
A quarterly results development with market-wide reach.
· Business Standard Mkts
Symbiotec Pharmalab has reported 52.8% fall in consolidated net profit to Rs 14.1 crore despite a 7% rise in revenue from operations to Rs 218.2 crore in Q1 FY27 as compared with Q1 FY26.
Key facts
- Period
- Q1 FY27 and Q1 FY26
The analysis
Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- The immediate tone of coverage reads negative.
Related coverage
TCS dividend 2026 record date, Q2 FY 2027 results announcement date and time, schedule, dividend history - Details
Q2 results today: TCS, Indian Bank, 4 others set to announce earnings
TCS shares rise ahead of Q2 results; Mphasis, Coforge, Infosys also gain; here's why
Fino Payments Bank share price rallies 17% after Q2 business update
ICICI Prudential Life Insurance to focus on growing absolute VNB amid slump in FY24